Current concepts in human prion protein (Prp) misfolding, Prnp gene polymorphisms and their contribution to Creutzfeldt-Jakob disease (CJD)

Histology and Histopathology

Volumn 22, Issue 10-12, 2007, Pages 1149-1159

  Michalczyk, K ^a   Ziman, Mel ^a  

^a EDITH COWAN UNIVERSITY   (Australia)

Author keywords

Creutzfeldt Jakob disease (CJD); Prion diseases; PRNP gene

Indexed keywords

AMYLOID PROTEIN; MESSENGER RNA; METHIONINE; PRION PROTEIN;

ALLELE; AMINO ACID SUBSTITUTION; CODON; COVALENT BOND; DISEASE COURSE; DISEASE TRANSMISSION; DISULFIDE BOND; DNA DETERMINATION; DNA POLYMORPHISM; EPIDEMIC; GENE IDENTIFICATION; GENE MUTATION; GENE STRUCTURE; GENETIC CODE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; INCUBATION TIME; MUTATIONAL ANALYSIS; NONHUMAN; PATHOGENESIS; PROTEIN FOLDING; PROTEIN PROCESSING; REVIEW; STRUCTURE ANALYSIS; UNITED KINGDOM; VARIANT CREUTZFELDT JAKOB DISEASE; ANIMAL; CHEMISTRY; CREUTZFELDT JAKOB DISEASE; DISEASE MODEL; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PRION; SEQUENCE ALIGNMENT; SHEEP; SPECIES DIFFERENCE; TRANSGENIC ANIMAL;

ANIMALIA;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BASE SEQUENCE; CREUTZFELDT-JAKOB SYNDROME; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PRIONS; PROTEIN FOLDING; SEQUENCE ALIGNMENT; SHEEP; SPECIES SPECIFICITY;

EID: 34547605379     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Aguzzi A., Montrasio F. and Kaeser P.S. (2001). Prions: health scare and biological challenge. Nature Rev. Mol. Cell Biol. 2, 118-126.
2. Alperovitch A., Zerr I., Pocchiari M., Mitrova E., de Pedro Cuesta J., Hegyi I., Collins S., Kretzschmar H., van Duijn C. and Will R.G. (1999). Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 353, 1673-1674.
3. Apetri A.C. and Surewicz W.K. (2002). Kinetic intermediate in the folding of Human Prion Protein. J. Biol. Chem. 277, 44589-44592.
4. Asante E.A. Linehan J.M., Desbruslais M., Joiner S., Gowland I., Wood A.L., Welch J., Hill A.F., Lloyd S.E., Wadsworth J.D. and Collinge J. (2002). BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J. 21, 6358-6366.
5. Baker H.E., Poulter M., Crow T.J., Frith C.D., Lofthouse R. and Ridley R.M. (1991). Aminoacid polymorphism in human prion protein and age at death in inherited prion disease. Lancet 337, 1286.
6. Balny C., Masson P. and Heremans K. (2002). High-pressure effects on biological macromolecules: from structural changes to alteration of cellular processes. Biochim. Biophys. Acta 1595, 3-10.
7. Baskakov I.V. (2004). Autocatalytic conversion of recombinant prion proteins displays a species barrier. J. Biol. Chem. 279, 7671-7677.
8. Baskakov I.V., Disterer P., Breydo L., Shaw M., Gill A., James W. and Tahiri-Alaoui A. (2005). The presence of valine at residue 129 in human prion protein accelerates amyloid formation. FEBS Lett. 579, 2589-2596.
9. Basler K., Oesch B., Scott M., Westaway D., Wälchli M., Groth D.F., McKinley M.P., Prusiner S.B. and Weissmann G. (1986). Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46, 417-428.
10. Baybutt H. and Manson J. (1997). Characterisation of two promoters for prion protein (PrP) gene expression in neuronal cells. Gene 184, 125-131.
11. Belay E. and Schonberger L. (2002). Variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Clin. Lab. Med. 22, 849-862.
12. Brandner S., Isenmann S., Raeber A., Fischer M., Sailer A., Kobayashi Y., Marino S., Weissmann C. and Aguzzi A. (1996a). Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339-343.
13. Brandner S., Raeber A., Sailer A., Blattler T., Fischer M., Weissmann C. and Aguzzi A. (1996b). Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system. Proc. Natl. Acad. Sci. USA 93, 13148-13151.
14. Brown P., Will R.G., Bradley R., Asher D.M. and Detwiler L. (2001). Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns. Emerg. Infect. Dis. 7, 6-16.
15. Brown D.R., Schmidt B. and Kretzschmar H.A. (1998). Effects of copper on survival of prion protein knockout neurones and glia. J. Neurochem. 70, 1686-1693.
16. Castilla J., Saa P., Hetz C. and Soto C. (2005). In vitro generation of infectious scrapie prions. Cell 121, 195-206.
17. Caughey B.W., Dong A., Bhat K.S., Ernst D., Hayes S.F. and Caughey W.S. (1991a). Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30, 7672-7680.
18. Caughey B., Raymond G.J., Ernst D. and Race R.E. (1991b). N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J. Virol. 65, 6597-6603.
19. Cervenakova L., Goldfarb L.G., Garruto R., Lee H.S., Gajdusek D.C. and Brown P. (1998). Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. USA 95, 13239-13241.
20. Collinge J., Palmer M.S. and Dryden A.J. (1991). Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 337, 1441-1442.
21. Collinge J., Whittington M.A., Sidle K.C., Smith C.J., Palmer M.S., Clarke A.R. and Jefferys J.G. (1994). Prion protein is necessary for normal synaptic function. Nature 370, 295-297.
22. Colon W. and Kelly J.W. (1991). Transthyretin acid induced denaturation is sufficient for amyloid fibril formation in vivo. Applications of enzyme biotechnology. Kelly J.W. and Balwin T.O. (eds). Plenum. New York. pp 99-108.
23. Colon W. and Kelly J.W. (1992). Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 31, 8654-8660.
24. Fasman G.D. (1998). Protein conformational prediction. Trends Biochem. Sci. 14, 295-299.
25. Gabizon R. and Taraboulos A. (1997). Of mice and (mad) cows transgenic mice help to understand prions. Trends Genet. 13, 264-269.
26. Gabizon R., McKinley M.P., Groth D. and Prusiner S.B. (1988). Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc. Natl. Acad. Sci. USA 85, 6617-6621.
27. Gasset M., Baldwin M.A., Fletterick R.J. and Prusiner S.B. (1993). Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc. Natl. Acad. Sci. USA 90, 10962-10966.
28. Gasset M., Baldwin M.A., Lloyd D.H., Gabriel J., Holtzman D.M., Cohen F., Fletterick R. and Prusiner S.B. (1992). Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid. Proc. Natl. Acad. Sci. USA 89, 10940-10944.
29. Hauw J.J. Sazdovitch V., Laplanche J.L., Peoc'h K., Kopp N., Kemeny J., Privat N., Delasnerie-Laupretre N., Brandel J.P., Deslys J.P., Dormont D. and Alperovitch A. (2000). Neuropathologic variants of sporadic Creutzfeldt-Jakob disease and codon 129 of PrP gene. Neurology 54, 1641-1646.
30. Herrmann L.M. and Caughey B. (1998). The importance of the disulfide bond in prion protein conversion. NeuroReport 9, 2457-2461.
31. Hill A.F., Desbruslais M., Joiner S., Sidle K.C., Gowland I., Collinge J., Doey L.J. and Lantos P. (1997). The same prion strain causes vCJD and BSE. Nature 389, 448-450.
32. Hilton D.A. (2006). Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease. J. Pathol. 208, 134-141.
33. Hilton D.A., Ghani A.C., Conyers L., Edwards P., McCardle L., Ritchie D., Penney M., Hegazy D. and Ironside J.W. (2004). Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J. Pathol. 203, 733-739.
34. Horiuchi M., Priola S.A., Chabry J. and Caughey B. (2000). Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers. Proc. Natl. Acad. Sci. USA 97, 5836-5841.
35. Horiuchi M. and Caughey B. (1999). Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J. 18, 3193-3203.
36. Hornemann S. and Glockshuber R. (1998). A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH. Proc. Natl. Acad. Sci. USA 95, 6010-6014.
37. Huang Z., Gabriel M.A., Baldwin M.A., Fletterick R.J, Prusiner S.B. and Cohen F.E. (1994). Proposed three-dimensional structure for the cellular prion protein. Proc. Natl. Acad. Sci. USA 91, 7139-7143.
38. Ironside J.W. (1998). Neuropathologic findings in new variant CJD and experimental transmission of BSE. FEMS Immunol. Med. Microbiol. 21, 91-95.
39. James T.L., Liu H., Ulyanov N.B., Farr-Jones, S., Zhang, H., Donne, D.G., Kaneko K., Groth D., Mehlhorn I., Prusiner S.B. and Cohen F.E. (1997). Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc. Natl. Acad. Sci. USA 94, 10086-10091.
40. Jarrett J.T. and Lansbury P.T. Jr (1993). Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058.
41. Jefferys J.G., Empson R.M., Whittington M.A. and Prusiner S.B. (1994). Scrapieinfection of transgenic mice leads to network and intrinsic dysfunction of cortical and hippocampal neurones. Neurobiol. Dis. 1, 25-30.
42. Kahana E., Alter M., Braham J. and Sofer D. (1974). Creutzfeldt-Jakob disease: focus among Libyan Jews in Israel. Science 183, 90-91.
43. Kapitonov V. and Jurka J. (1996). The age of Alu subfamilies. J. Mol. Evol. 42, 59-65.
44. Kelly J.W. (1996). Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol. 6, 11-17.
45. Kelly J.W. (1997). Amyloid fibril formation and protein misassembly: a structural quest for insights into amyloid and prion diseases. Structure 5, 595-600.
46. Kelly J.W. (1998). The environmental dependency of protein folding best explains prion and amyloid diseases. Proc. Natl. Acad. Sci. USA 95, 930-932.
47. Knight R.S. and Will R.G. (2004). Prion diseases. J. Neurol. Neurosurg. Psychiatry 75, 36-42.
48. Kocisko D.A., Come J.H., Priola S.A., Chesebro B., Raymond G.J., Lansbury P.T. and Caughey B. (1994). Cell-free formation of protease-resistant prion protein. Nature 370, 471-474.
49. Kretzschmar H.A., Prusiner S.B., Stowring L.E., and DeArmond S.J. (1986). Scrapie prion proteins are synthetized in neurons. Am. J. Pathol. 122, 1-5.
50. Lansbury P.T. (1992). In pursuit of the molecular structure of amyloid plaque: new technology provides unexpected and critical information. Biochemistry 31, 6865-6870.
51. Laplanche J.L., Delasnerie-Laupretre N., Brandel J.P., Chatelain J., Beaudry P., Alperovitch A. and Launay J.M. (1994). Molecular genetics of prion diseases in France. French research group on epidemiology of human spongiform encephalopathies. Neurology 44, 2347-2351.
52. Lee I.Y., Westaway D., Smit A.F.A., Wang K., Seto J., Chen L., Acharya C., Ankener M., Baskin D., Cooper C., Yao H., Prusiner S.B. and Hood L.E. (1998). Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. Genome Res. 8, 1022-1037.
53. Li G. and Bolton D.C. (1997). A novel hamster prion protein mRNA contains an extra exon: Increased expression in scrapie. Brain Res. 751, 265-274.
54. Ma J., Wollmann R. and Lindquist S. (2002). Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298, 1781-1785.
55. Mahal S.P., Asante E.A., Antoniou M. and Collinge J. (2001). Isolation and functional characterisation of the promoter region of the human prion protein gene. Gene 268, 105-114.
56. Manson J.C., Hope J., Clarke A.R., Johnston A., Black C. and MacLeod N. (1995). PrP gene dosage and long term potentiation. Neurodegeneration 4, 113-114.
57. Masters C.L., Harris J.O., Gajdusek D.C., Gibbs C.J. Jr, Bernoulli C. and Asher D.M. (1979). Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann. Neurol. 5, 177-188.
58. Mead S., Mahal S.P., Beck J., Campbell T., Farrall M., Fisher E. and Collinge J. (2001). Sporadic - but not variant - Creutzfeldt-Jakob disease is associated with polymorphisms upstream of PRNP Exon 1. Am. J. Hum. Genet. 69, 1225-1235.
59. Morillas M., Vanik D.L. and Surewicz W.K. (2001). On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein. Biochemistry 40, 6982-6987.
60. Muramoto T., Scott M., Cohen F.E. and Prusiner S.B. (1996). Recombinant scrapie-like prion protein of 106 amino acids is soluble. Proc. Natl. Acad. Sci. USA 93, 15457-15462.
61. Palmer M.S., Dryden A.J., Hughes J.T. and Collinge J. (1991). Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352, 340-342.
62. Parchi P., Giese A., Capellari S., Brown P., Schulz-Schaeffer W., Windl O., Zerr I., Budka H., Kopp N., Piccardo P., Poser S., Rojiani A., Streichemberger N., Julien J., Vital C., Ghetti B., Gambetti P. and Kretzschmar H. (1999). Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 46, 224-233.
63. Pekari K. and Schmidt R.R. (2003). A variable concept for the preparation of branched glycosyl phosphatidyl inositol anchors. J. Org. Chem. 68, 1295-1308.
64. Prusiner S.B. (1996). Molecular biology and pathogenesis of prion diseases. Trends Biochem. Sci. 21, 482-487.
65. Prusiner S.B. (1997). Prion diseases and the BSE crisis. Science 278, 245-251.
66. Prusiner S.B. (1998). Prions. Proc. Natl. Acad. Sci. USA 95, 13363-13383.
67. Puckett C., Concannon P., Casey C. and Hood L. (1991). Genomic structure at the human prion protein gene. Am. J. Hum. Genet. 49, 320-329.
68. Raymond G.J., Hope J., Kocisko D.A., Priola S.A., Raymond L.D., Bossers A., Ironside J., Will R.G., Chen S.G., Petersen R.B., Gambetti P., Rubenstein R., Smits M.A., Lansbury P.T. Jr and Caughey B. (1997). Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature 388, 285-288.
69. Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R. and Wuthrich K. (1996). NMR structure of the mouse prion protein domain PrP(121-321). Nature 382, 180-182.
70. Riek R., Hornemann S., Wider G., Glockshuber R. and Wuthrich K. (1997). NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett. 413, 282-288.
71. Santini S., Claude J.B., Audic S. and Derreumaux P. (2003). Impact of the tail and mutations G131V and M129V on prion protein flexibility. Proteins 51, 258-265.
72. Schulz-Schaeffer W.J., Giese A., Windl O. and Kretzschmar H.A. (1996). Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease. Clin. Neuropathol. 15, 353-357.
73. Scott M., Groth D., Foster D., Torchia M., Yang S.L., DeArmond S.J. and Prusiner S.B. (1993). Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell 73, 979-988.
74. Smit A.F.A. (1996). The origin of interspersed repeats in the human genome. Curr. Opin. Genet. Dev. 6, 743-748.
75. Smit A.F., Tóth G., Riggs A.D. and Jurka J. (1996). Ancestral, mammalian-wide subfamilies of LINE1 repetitive sequences. J. Mol. Biol. 246, 401-417.
76. Smit A.F.A. and Riggs A.D. (1995). Tiggers and DNA transposon fossils in the human genome. Proc. Natl. Acad. Sci. USA 93, 1443-1448.
77. Stahl N., Bladwin M.A., Burlingame A.L. and Prusiner S.B. (1990). Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry 29, 8879-8884.
78. Stahl N., Borchelt D.R., Hsiao K. and Prusiner S.B. (1987). Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51, 229-240.
79. Sunde D.R., Bellott M., Robinson V., Hutchinson C.V., Fraser W.L., Hawkins P.E., Dobson P.N., Radford C.M., Blake S.E. and Pepys M.B. (1997). Nature 385, 787-793.
80. Swietnicki W., Petersen R., Gambetti P. and Surewicz W.K. (1997). pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231). J. Biol. Chem. 272, 27517-27520.
81. Tahiri-Alaoui A. and James W. (2005). Rapid formation of amyloid from {alpha}-monomeric recombinant human PrP in vitro. Protein Sci. 14, 942-947.
82. Telling G.C., Scott M., Mastrianni J., Gabizon R., Torchia M., Cohen F.E., DeArmond S.J. and Prusiner S.B. (1995). Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83, 79-90.
83. Torrent J., Alvarez-Martinez M.T., Heitz F., Liautard J.P. Balny C. and Lange R. (2003). Alternative prion structural changes revealed by high pressure. Biochemistry 42, 1318-1325.
84. Torrent J., Alvarez-Martinez M.T., Harricane M.C., Heitz F., Liautard J.P., Balny C. and Lange R. (2004). High pressure induces scrapie-like prion protein misfolding and amyloid fibril formation. Biochemistry 43, 7162-7170.
85. Van Eldik R., Asano T. and Le Noble W.J. (1989). Activation and reaction volume in solution 2. Chem. Rev. 89, 549-688.
86. Wadsworth J.D., Asante E.A., Desbruslais M., Linehan J.M., Joiner S., Gowland I., Welch J., Stone L., Lloyd S.E., Hill A.F., Brandner S. and Collinge J. (2004). Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306, 1793-1796.
87. Welker E., Wedemeyer W.J. and Scheraga H.A. (2001). A role for intermolecular disulfide bonds in prion diseases? Proc. Natl. Acad. Sci. USA 98, 4334-4336.
88. Will R.G., Alpers M.P., Dormont D. and Schonberger L.B. (2004). Infectious and sporadic prion diseases. In: Prion biology and diseases. Prusiner S.B. (ed). Cold Spring Harbor Laboratory Pres. New York. pp 629-671.
89. Windl O., Dempster M., Estibeiro J.P., Lathe R., de Silva R., Esmonde T., Will R., Springbett A., Campbell T.A., Sidle K.C., Palmer M.S. and Collinge J. (1996). Genetic basis of Creutzteldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum. Genet. 98, 259-264.
90. Yoshimoto J., Iinuma T., Ishiguro N., Horiuchi M., Imamura M. and Shinagawa M. (1992). Comparative sequence analysis and expression of bovine PrP gene in mouse L-929 cells. Virus Genes 6, 343-356.
91. Zaborowski A. (2004). Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies, Part II. Psychiatr. Pol. 38, 297-309.